[go: up one dir, main page]

DE68916234D1 - Pharmazeutische zubereitungen für neuroschutz, die arylcyclohexylamine enthalten. - Google Patents

Pharmazeutische zubereitungen für neuroschutz, die arylcyclohexylamine enthalten.

Info

Publication number
DE68916234D1
DE68916234D1 DE68916234T DE68916234T DE68916234D1 DE 68916234 D1 DE68916234 D1 DE 68916234D1 DE 68916234 T DE68916234 T DE 68916234T DE 68916234 T DE68916234 T DE 68916234T DE 68916234 D1 DE68916234 D1 DE 68916234D1
Authority
DE
Germany
Prior art keywords
arylcyclohexylamine
pct
radical
hydrogen atom
image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68916234T
Other languages
English (en)
Other versions
DE68916234T2 (de
Inventor
Jean-Marc Kamenka
Alain Privat
Robert Chicheportiche
Gerard Rondouin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Publication of DE68916234D1 publication Critical patent/DE68916234D1/de
Application granted granted Critical
Publication of DE68916234T2 publication Critical patent/DE68916234T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE68916234T 1988-11-21 1989-11-20 Pharmazeutische zubereitungen für neuroschutz, die arylcyclohexylamine enthalten. Expired - Lifetime DE68916234T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8815106A FR2639225B1 (fr) 1988-11-21 1988-11-21 Compositions pharmaceutiques pour la neuroprotection contenant des arylcyclohexylamines
PCT/FR1989/000596 WO1990005524A2 (fr) 1988-11-21 1989-11-20 Compositions pharmaceutiques pour la neuroprotection contenant des arylcyclohexylamines

Publications (2)

Publication Number Publication Date
DE68916234D1 true DE68916234D1 (de) 1994-07-21
DE68916234T2 DE68916234T2 (de) 1995-02-02

Family

ID=9372035

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68916234T Expired - Lifetime DE68916234T2 (de) 1988-11-21 1989-11-20 Pharmazeutische zubereitungen für neuroschutz, die arylcyclohexylamine enthalten.

Country Status (9)

Country Link
US (1) US5179109A (de)
EP (1) EP0396734B1 (de)
JP (1) JP2935137B2 (de)
AT (1) ATE107167T1 (de)
CA (1) CA2003388C (de)
DE (1) DE68916234T2 (de)
ES (1) ES2056440T3 (de)
FR (1) FR2639225B1 (de)
WO (1) WO1990005524A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE411809T1 (de) 1993-04-30 2008-11-15 Wellstat Biologics Corp Zusuammensetzungen zur behandlung von krebs mittels viren
IL110309A0 (en) * 1993-07-15 1994-10-21 Univ Kentucky Res Found A method of protecting against neuron loss
US5972952A (en) * 1995-12-11 1999-10-26 Le Centre National De La Recherche Scientifique Neuroprotective pharmaceutical composition containing stereoisomers of arylcyclohexylamines
US6207685B1 (en) * 1996-12-06 2001-03-27 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Therapeutic application of a thienycyclohexylamine derivative
FR2756738B1 (fr) * 1996-12-06 1999-02-12 Sod Conseils Rech Applic Nouvelle application therapeutique d'un derive de la thienylcyclohexylamine
US6784194B2 (en) * 1996-12-06 2004-08-31 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Therapeutic use of a thienylcyclohexylamine derivative
FR2763589B1 (fr) * 1997-05-22 2001-01-05 Centre Nat Rech Scient Composes pour la preparation de medicaments destines au traitement de pathologies impliquant le glutamate extracellulaire, et leurs procedes d'obtention
CA2370030C (en) * 1999-04-09 2007-08-14 Euro-Celtique S.A. Sodium channel blocker compositions and the use thereof
FR2818147B1 (fr) * 2000-12-20 2005-06-10 Sod Conseils Rech Applic Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine
JP4350508B2 (ja) 2001-09-03 2009-10-21 ニユーロン・フアーマシユーテイカルズ・エツセ・ピー・アー ガバペンチンまたはその類似体とα−アミノアミドとを含む薬剤組成物およびその鎮痛用途
US20040082543A1 (en) * 2002-10-29 2004-04-29 Pharmacia Corporation Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain
TW571449B (en) * 2002-12-23 2004-01-11 Epistar Corp Light-emitting device having micro-reflective structure
FR2858934B1 (fr) * 2003-08-22 2006-12-29 Helene Hirbec Composition pharmaceutique et son application dans le domaine de la neurologie en tant qu'agent modulateur du systeme glutamatergique
SI1809271T1 (sl) * 2004-09-10 2010-10-29 Newron Pharm Spa Uporaba (R)-(halobenziloksi) benzilamino propanamidov kot selektivnih modulatorjev natrijevih in/ali kalcijevih kanalov
FR2946535B1 (fr) 2009-06-10 2011-09-09 Neureva Composition comprenant une molecule favorisant l'interaction neurone-glie, notamment pour prevenir la formation de la cicatrice gliale et induire la regeneration neurale.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE565254A (de) * 1957-09-19
JPS57150361A (en) * 1981-03-10 1982-09-17 Ajinomoto Co Inc Granule of dipeptide sweetener
JPS57155965A (en) * 1981-03-19 1982-09-27 Ajinomoto Co Inc Low-calorie sweetening composition
JPS58155054A (ja) * 1982-03-10 1983-09-14 Ajinomoto Co Inc ジペプチド甘味料含有糖結晶及びその製造法
JPS5959173A (ja) * 1982-09-29 1984-04-04 Ajinomoto Co Inc 甘味料顆粒又はキユ−ブの製造法
JPS60188038A (ja) * 1984-03-09 1985-09-25 Toyo Soda Mfg Co Ltd 自由流動性低カロリ−甘味料組成物

Also Published As

Publication number Publication date
CA2003388C (fr) 2001-06-12
JPH03505214A (ja) 1991-11-14
FR2639225A1 (fr) 1990-05-25
CA2003388A1 (fr) 1990-05-21
ES2056440T3 (es) 1994-10-01
WO1990005524A3 (fr) 1990-11-29
FR2639225B1 (fr) 1993-05-21
EP0396734A1 (de) 1990-11-14
WO1990005524A2 (fr) 1990-05-31
EP0396734B1 (de) 1994-06-15
ATE107167T1 (de) 1994-07-15
US5179109A (en) 1993-01-12
DE68916234T2 (de) 1995-02-02
JP2935137B2 (ja) 1999-08-16

Similar Documents

Publication Publication Date Title
DE68916234D1 (de) Pharmazeutische zubereitungen für neuroschutz, die arylcyclohexylamine enthalten.
DE69110625D1 (de) Oxazolopyridinderivate, Verfahren zu ihrer Herstellung und die sie enthaltenden pharmazeutischen Zusammensetzungen.
ATE6507T1 (de) Piperidinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE69225484D1 (de) Gallium iii komplexe, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten
ATE113029T1 (de) Hustenstillendes und schleimregulierendes mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
DE69206214D1 (de) Neue Arylethylaminderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
FI945081A0 (fi) Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformulaatioon
DE69409337D1 (de) Verzweigte Aminothiazole-Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammenstellungen die sie enthalten
ES2086771T3 (es) Composicion dermatologica y/o cosmetologica que contiene retinoides.
ES2055637T3 (es) Nuevos compuestos poli-yodados, procedimiento de preparacion, producto de contraste que los contiene.
DE69424734D1 (de) Phenyl-Carboxamide-Isoxazole-Derivate und Salze, Verfahren zu ihrer Herstellung ihre Anwendung als Arzneimittel und pharmazeutische Zusammensetzungen die sie enthalten
DE3369983D1 (en) Isoquinoline derivatives, process for their preparation, pharmaceutical compositions containing them and their use
IL108856A0 (en) Hydroxymethyl-furazancarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
ATE175344T1 (de) Gelbildende präparate, die optisch angereicherte gelbildner enthalten
IL72668A (en) Hydroxyalkyl(and hydroxyalkoxy)benzoic acid derivatives,their preparation and pharmaceutical compositions containing them
DE69006647D1 (de) 5,6,7,8-Tetrahydro-1-naphthalenolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Antioxidationsmittel in kosmetischen und pharmazeutischen Zusammensetzungen.
ATE43350T1 (de) Nor-cholsaeure-derivate, verfahren zu ihrer herstellung, ihre anwendung und pharmazeutische zusammenstellungen, die sie enthalten.
TW261605B (de)
TW248530B (de)
ZA903628B (en) Novel 9alpha-hydroxy-3-oxo-4,24(25)-stigmastadien-26-oic acid derivatives,a process for preparing same and pharmaceutical compositions containing same
KR970704463A (ko) 스트렙토그라민 유도체, 이의 제조 방법 및 이를 함유하는 약학 조성물(streptogramine derivatives, preparation of same and pharmaceutical compositions containing same)
ES8307242A1 (es) Un procedimiento para la preparacion de 3(2-(3-alquil y alquenil-4-piperidil))indoles.
HUT53096A (en) Process for producing thienylacetic acid derivatives and pharmaceutical compositions comprising same
HU901631D0 (en) Process for the preparation of thienyl-piperazine derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
8364 No opposition during term of opposition